For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit


Weill Cornell Medicine’s Office of Diversity and Inclusion has been recognized as a Diversity Champion by Crain’s New York Business as part of its first annual Excellence in Diversity and Inclusion Awards, announced July 15.

The Diversity Champion award recognizes organizations in all industries that have committed to a diverse workforce and have programs or initiatives advancing the promotion of diversity in the workplace. Weill Cornell Medicine won in the large-company category.


Read More

The genetic changes that underlie an especially lethal type of prostate cancer have been revealed in a new study by investigators at Weill Cornell Medicine. Learning more about what causes this type of cancer, called neuroendocrine prostate cancer (NEPC), could lead to new approaches for treating it.

Most early-stage prostate cancers require male hormones (androgens) like testosterone to grow. However, as they advance, they may evolve into castration-resistant prostate cancer (CRPC), a...

Read More

Video of We're Changing Medicine - Campaign Launch Event

NEW YORK (June 17, 2021) — Building on a legacy of groundbreaking advances in medicine and science, Weill Cornell Medicine today launched an ambitious $1.5 billion campaign—with more than $750 million already raised—that will harness emerging biomedical innovations to bring exemplary care to patients and create enduring change in medicine.

The We’re Changing Medicine campaign is the...

Read More

SARS-CoV-2, the virus causing the global COVID-19 pandemic, can infect human pancreatic cells and alter their physiology, according to research from Weill Cornell Medicine and NewYork-Presbyterian investigators. Though the results come from analyses of autopsy samples and cultured cells and don't prove a direct causal relationship, they dovetail with clinical reports of glucose control problems in COVID-19 patients, suggesting a new dimension of disease development for a virus that has...

Read More

The Weill Cornell Graduate School of Medical Sciences honored the students in the Class of 2021 for their academic achievements during a virtual convocation ceremony on May 19. Students and their families and friends watched a livestream of the event, as graduate school faculty announced the recipients of special awards and prizes.

“While our convocation celebration looks different than our traditional ceremony, taking time to acknowledge the dedication, perseverance and scientific...

Read More

A team led by researchers at Weill Cornell Medicine and Children’s National Hospital has developed a unique pre-clinical model that enables the study of long-term HIV infection, and the testing of new therapies aimed at curing the disease.

Ordinary mice cannot be infected with HIV, so previous HIV mouse models have used mice that carry human stem cells or CD4 T cells, a type of immune cell that can be infected with HIV. But these models tend to have limited utility because the human...

Read More

Dr. Giovanni Manfredi, the Finbar and Marianne Kenny Professor in Clinical and Research Neurology at Weill Cornell Medicine’s Feil Family Brain and Mind Research Institute, has received an Outstanding Investigator Award (R35) from the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS) to study the role of mitochondrial dysfunction in brain disease.

The highly competitive award provides long-term support and flexibility for an investigator to...

Read More

Gut bacteria play an important role in the body’s response to treatment for tuberculosis (TB), according to researchers at Weill Cornell Medicine and Memorial Sloan Kettering. Because current treatments for TB involve long courses of antibiotics, which are known to disrupt the balance of microbes in the gut, a better understanding of these interactions may help in predicting outcomes to therapy and suggest ways to improve it.

In their study, published Feb. 18 in Nature Communications,...

Read More

A team led by scientists at Weill Cornell Medicine has made a map identifying all the different RNA molecules that are derived from each gene in the brains of mice. It is the first map that depicts this important layer of biological diversity, called isoform variation, by cell type and across brain regions for the whole genome, and it contributes to neuroscientists’ ambitious goal of an ultra-detailed atlas of the brain.

Isoform variation is a process that extends the versatility of...

Read More

Weill Cornell Medicine Graduate School of Medical Sciences 1300 York Ave. Box 65 New York, NY 10065 Phone: (212) 746-6565 Fax: (212) 746-5981